WPRIM Management System> DCMS> Chinese Journal of Practical Internal Medicine> 2019> 39> 05

Volume: 39 Issue: 05

1. Lung cancer and respiratory comorbidities Page:399—402
2. Progress in immunotherapy targeting PD-1/PD-L1 for lung cancer Page:403—406
3. Molecular diagnostics of lung cancer and its research progress Page:407—411
4. Lung cancer and respiratory commorbidity Page:412—415
5. Diagnosis and treatment strategy for advanced severe lung cancer Page:416—419
6. Progress in diagnosis and treatment of stage ⅠA lung cancer Page:420—430
7. Problems and thoughts in diagnosis and treatment of chronic obstructive pulmonary disease Page:425—430
8. Interpretation of the guidelines for clinical diagnosis of idiopathic pulmonary fibrosis in 2018 Page:431—436
9. Interpretation of expert consensus on diagnosis and treatment of eosinophilic granulomatous polyvasculitis in 2018 Page:437—439
10. Interpretation of chinese expert consensus on the diagnosis and treatment of pulmonary nodules(2018 version) Page:440—442
11. Treatment for latent tuberculosis infection in China: advantages or disadvantages Page:443—446
12. Distribution of pathogenic bacteria and drug resistance analysis in patients with acute exacerbation of chronic obstructive pulmonary disease Page:447—451
13. Decitabine combined with arsenious acid in the treatment of patients with higher-risk myelodysplastic syndromes and chronic myelomonocytic leukemia Page:452—455
14. Clinical follow-up study on the treatment of middle cerebral artery stenosis with balloon-expandable stent: 67 cases analysis Page:456—459
15. First-generation epithelial growth factor receptor tyrosine kinase inhibitor in the first-line treatment of advanced non-small cell lung cancer: 166 cases analysis of progression-free survival Page:460—463
16. Develop standardized lung function training to help prevent and control chronic respiratory diseases Page:481—484

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.